Riobard

Not how that term is employed. Rather, for example, ‘you behave in the very manner that you criticize in others.’ Behaviour is not projectable as it is external, not an introject.

Gross oversimplifications not supported by qualitative research on MSM’s awareness and attitudes regarding viral and bacterial STIs.

KFC antidote [4 minutes] (Don’t get me wrong; ❤️ me some Colonel; don’t have in Québec) RPReplay_Final1704078083.mov

“A big temple” in Bangkok. Shoes also off. Who knew?

Unless it’s Briddish or Disstrikt.

Yes, it’s clear you yank the arms off little kids’ teddy bears as well as helpless insects and the occasional amphibian here and there.

Just a few hours, but I register surprise. 2 venues opposite sides of world with common theme and I assumed of some familiarity among those not bullshitting about travels and not generally bullshitfaced when attending. By the way, dumbelinas’ downvotes rack up reputation badge merit points just like any other category. Mwahahah. I’m too cheap a bitch; otherwise my fingerprints would be worn down.

The important thing is my being prepared and refraining from assuming somebody is short a few deck cards when they may be just jerking my chain.

Yes. Plus one. Did you think I was on a soapbox? Plus Molina’s research similarly tripped into the same observation more by accident than design, and as I indicated it’s Eff around 50% was (and is) apparently questioned by external peers. The product innocuousness level factor concomitant with preliminary and refutable effectiveness findings does not substitute for the rigour of currently running focused trials. One study (Oregon unis?) observed a lower GC incidence rate comparing Outer Membrane Vesicle MBV (the format driver of contemporary research) to non-OMV MBV, thousands in each category subgroup of MBV recipients. Observational but not a VaxxPoz vs VaxxNeg binary scenario that, as you astutely point out, introduces behavioural confounder effects. Unfortunately, it’s taking several years to execute the research yet one must not succumb to impatience by recklessly accepting prematurity.

Two opposing concepts cannot easily be both true. The second part is true because there exists no extant research that substantiates the claim of the first part, likely simply an extraneous comment on the general merits of cleanliness’ adjacency to godliness.

Haha … you locals swoop in, pluck the choicest, and leave us mere hapless ‘tourons’ with the scraps. Not that I have any reason to whine about my time. 😉

UK to proceed with MeningicoccalB vaccine for gonorrhoea (aka gonococcal, gonorrhea for search term optimization) based on the findings to date that have propelled the further ongoing research. https://www.statnews.com/2023/11/10/u-k-recommendation-could-lead-to-worlds-first-use-of-meningitis-vaccine-to-curb-gonorrhea/ Meanwhile, I read a few months ago that Molina’s promising-looking findings on the MeningicoccalB vaxx component of his Doxycycline prophylaxis research had been challenged, and the methodology and vaccination results were to undergo audit. Haven’t seen any updates. It may be just a question of downgrading the efficacy metric. Lower vaxx efficacy for a disease tends to be more acceptable where infection recidivism is common. In many jurisdictions including Canada and USA, Bexsero (GSK Pharma) is authorized up to age 25 for meningitis prevention. Administering off-label for gonorrhea prevention efforts should be considered case-by-case and I expect many STI clinics and savvy HCPs will get on board. Me, I can pass for minimally one year younger and I’m not sure if my occasional use of Depends briefs puts me in the running for childhood Bexsero uptake. My condom use is also far from occasional.

I just had t’ one from there. Could we now be minimal degrees of separation DNA-bros by bridging over the river Thai proxy? Odds 10:1?

For me and life’s loves it’s a they, the plural they not to be confused with the non-binary they, and some of those rides reverse cowboy. Want the ‘jizz’ from that ‘rizz’.

On 1-2-2-4, A or B? [43 seconds] My Movie.mov

The main distinction seems to be Visitor versus Temporary, with over a dozen subcategories across the two. In this case, the remote work seems feasible within several categories because not associated with a Brazilian institution. A central question would be length of stay per entry. The e-visa is Visitor category and mandatory but seems might be more limited in stay duration allowances and total annualized days allowed. Thus, choice of type may be worth exploring by the candidate depending on anticipated preferences that may emerge, covering a specific set of circumstances and bypassing the need to later transition between visa formats.

Since the contingency of an eventual segue from a 1-month visit to longer durations is now included in the mix (what do I know? and how can I know your entry privileges in the absence of context?), not remote, I recommend deep-diving into the implications and relative merits of acquiring a consular visa versus the recently reinstated e-visa requirement. It may be worth pursuing a consular visa up front. If a foreign national that is subject to visa necessity and is granted the e-visa 5 or 10 years (these are linked irreversibly to passport), and if a consular visa is possibly later preferable in terms of privileges conferred (eg, visit durations etc), you may get more assiduously grilled if desiring to later supplant the e-visa with said consular visa. Throwing good money after bad may raise eyebrows. AFAIK, Americans in either visa category acquire 10 years, Australians and Canadians 5 years. Compare the number of annual days allowed, the start and endpoint number of days allowed per entry, and extension contingencies that may involve local federal police authorizations, etc. That said, there are likely far better candidates than me to weigh in on this aspect, based on their own experience. Otherwise, more sunblock?

OP indicates a month, one month (!), a duration matched, exceeded, and plunged into by most posters on this board that travel to Brazil irrespective of other obligations when there. Therefore, in what way does remote employment status uniquely enter into how to plan the playbook, other than structuring time and activity in a particular way and protecting company gear from out-calls? Or just do this:

Maybe there are braille formats of the aforementioned brochures.

The ones I follow have an “X” symbol and the content sure reflects that rating grade. I especially like the ones where my historical in-person choreography with them generally replicates that of the majority of their clip scenes. Although much more external prophylaxis.

Maps be keeping nosy neighbours running in circles and in the dark. LOL.

Meanwhile the GSK investigational gonorrhoea vaccine study is recruiting in Brazil, among several other global locations.

The biggest and alarming incidence escalation is in congenital syphilis, therefore the increase is considerably disproportionate among women of childbearing age. That skew alone reveals little in terms of MSM rate trends and their reproductive crossover. In terms of gonococcal infection prophylaxis research the Meningococcal Group B vaccine (Bexsero) placebo-control trial underway, with results still a few years off, now has recruitment in 2 Bangkok locations.